TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/20/2023
Back to search
Official data from USPTO
IFORMULATE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IFORMULATE
ST13
US500000090713374Class
1, 42
Filing
90713374
Registration
6743350
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
04/20/2023
Trademark type
Word
Nice classes
1, 42
Filing date
05/15/2021
Registration date
05/31/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/31/2022
Last transaction
05/31/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/28/2010
First use in commerce
06/28/2010
Drawing code
4
Owner type
03
Owner location
Pleasanton, CA
Examiner
WHITE, TRAVIS WILLIAM
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
HTD Biosystems, Inc.
Representatives
Micah Drayton CALDWELL INTELLECTUAL PROPERTY LAW
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of liquid formulations of proteinsantibodiespeptidesother small moleculesfor use in evaluating their respective solubility propertiesall the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of nanoparticle formulationsincluding investigating parameters related to drug releaseparticle sizeaggregationsdrug integrityall the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of vaccine stability formulationsall the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of antibody conjugates and antibody drug conjugates (ADCs)all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of diagnostic reagents and for use in evaluating their stability and compatibility in various formulations with respect to the effect of pHionic strengthbuffer and stability concentrationsall the foregoing using Design of Experiments Approach in a multivariate fashion
Class 42
Scientific research services related to providing an optimum process for identifying stable formulations for biotech drugs such as proteinpeptidessmall moleculesusing advanced Design of Experiments strategy; Scientific laboratory services related to providing an optimum process for identifying stable formulations for biotech drugs such as proteinpeptidessmall moleculesusing advanced Design of Experiments strategy
Publications
History of USPTO decisions and trademark events.
19 publications found
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/20/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/20/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/20/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/31/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/31/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/15/2022
PUBO
PUBLISHED FOR OPPOSITION
03/15/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/23/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/10/2022
ALIE
ASSIGNED TO LIE
02/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/04/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
01/31/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/31/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
01/31/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/31/2022
DOCK
ASSIGNED TO EXAMINER
01/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/13/2021
NWAP
NEW APPLICATION ENTERED
05/19/2021
Continuous trademark protection
Get notified about every new filing that threatens IFORMULATE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.